Victory Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$452K Buy
16,088
+1,964
+14% +$52.3K 0.06% 201
2025
Q4
$352K Buy
14,124
+3,084
+28% +$77.8K 0.04% 219
2025
Q3
$284K Buy
11,040
+2,727
+33% +$67.3K 0.04% 197
2025
Q2
$202K Buy
+8,313
New +$194K 0.03% 222

Other funds holding PFE

Victory Financial Group's PFE Position: Q1 2026 in Review

Victory Financial Group increased its Pfizer (PFE) stake by 14% in Q1 2026, buying an estimated $52.3K and bringing the position to 16,088 shares worth $452K. The position accounts for 0.06% of the portfolio, ranked #201.

Victory Financial Group first reported a position in PFE in Q2 2025 and has held it in 4 quarters since. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Victory Financial Group held 16,088 shares of Pfizer worth $452K as of Q1 2026.
  • Victory Financial Group bought 1,964 Pfizer shares in Q1 2026, an estimated $52.3K.
  • Pfizer made up 0.06% of Victory Financial Group's portfolio in Q1 2026, its #201 holding.
  • Victory Financial Group first reported a position in Pfizer in Q2 2025 and has held it in 4 quarters since.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Victory Financial Group's 13F filing for Q1 2026, filed 27 Apr 2026.